
Christian C. Boesen
Examiner (ID: 11357, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 4131, 1675, 1636, 1639, 1684 |
| Total Applications | 995 |
| Issued Applications | 677 |
| Pending Applications | 91 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16328717
[patent_doc_number] => 20200299683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/860217
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860217 | METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS | Apr 27, 2020 | Abandoned |
Array
(
[id] => 17953785
[patent_doc_number] => 11479880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Fibronectin type III domain based scaffold compositions, methods and uses
[patent_app_type] => utility
[patent_app_number] => 16/860613
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25853
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860613 | Fibronectin type III domain based scaffold compositions, methods and uses | Apr 27, 2020 | Issued |
Array
(
[id] => 17756433
[patent_doc_number] => 11396717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Comprehensive monoclonal antibody generation
[patent_app_type] => utility
[patent_app_number] => 16/859150
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29076
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859150 | Comprehensive monoclonal antibody generation | Apr 26, 2020 | Issued |
Array
(
[id] => 17749933
[patent_doc_number] => 20220228138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHOD FOR PREPARING PHAGE LIBRARY
[patent_app_type] => utility
[patent_app_number] => 17/605409
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605409 | Method for preparing phage library | Apr 19, 2020 | Issued |
Array
(
[id] => 16222792
[patent_doc_number] => 20200247908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => GENERATION OF BINDING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/852184
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16852184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/852184 | Generation of binding molecules | Apr 16, 2020 | Issued |
Array
(
[id] => 17822990
[patent_doc_number] => 11427932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Materials and methods for protein production
[patent_app_type] => utility
[patent_app_number] => 16/852232
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 7
[patent_no_of_words] => 46688
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16852232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/852232 | Materials and methods for protein production | Apr 16, 2020 | Issued |
Array
(
[id] => 16438372
[patent_doc_number] => 20200355698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES
[patent_app_type] => utility
[patent_app_number] => 16/844088
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844088 | USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES | Apr 8, 2020 | Abandoned |
Array
(
[id] => 17742907
[patent_doc_number] => 11390964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Polyclonal mixtures of antibodies, and methods of making and using them
[patent_app_type] => utility
[patent_app_number] => 16/844255
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 37923
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 315
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844255 | Polyclonal mixtures of antibodies, and methods of making and using them | Apr 8, 2020 | Issued |
Array
(
[id] => 18233475
[patent_doc_number] => 11598024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
[patent_app_type] => utility
[patent_app_number] => 16/838910
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34983
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838910 | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs | Apr 1, 2020 | Issued |
Array
(
[id] => 16621529
[patent_doc_number] => 20210040182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => HUMANIZED ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/836986
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16836986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/836986 | Humanized antibodies | Mar 31, 2020 | Issued |
Array
(
[id] => 16558436
[patent_doc_number] => 20210003585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => METHOD
[patent_app_type] => utility
[patent_app_number] => 16/833995
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833995
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833995 | Methods for labelling, analyzing, detecting and measuring protein-protein interactions | Mar 29, 2020 | Issued |
Array
(
[id] => 18071667
[patent_doc_number] => 11530493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Humanized antibodies with ultralong complementary determining regions
[patent_app_type] => utility
[patent_app_number] => 16/831508
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 113
[patent_figures_cnt] => 26
[patent_no_of_words] => 91945
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831508 | Humanized antibodies with ultralong complementary determining regions | Mar 25, 2020 | Issued |
Array
(
[id] => 17657406
[patent_doc_number] => 20220177871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHOD FOR CONSTRUCTING CHIMERIC PLASMID LIBRARY
[patent_app_type] => utility
[patent_app_number] => 17/600836
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600836 | Method for constructing chimeric plasmid library | Mar 23, 2020 | Issued |
Array
(
[id] => 16312651
[patent_doc_number] => 20200291389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => COMBINATORIAL PHOTO-CONTROLLED SPATIAL SEQUENCING AND LABELING
[patent_app_type] => utility
[patent_app_number] => 16/821917
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821917 | Combinatorial photo-controlled spatial sequencing and labeling | Mar 16, 2020 | Issued |
Array
(
[id] => 17784980
[patent_doc_number] => 11408093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Fibronectin binding domains with reduced immunogenicity
[patent_app_type] => utility
[patent_app_number] => 16/813094
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 31766
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813094 | Fibronectin binding domains with reduced immunogenicity | Mar 8, 2020 | Issued |
Array
(
[id] => 17807750
[patent_doc_number] => 20220259585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS OF MAKING AND UTILIZING AMBER-OBLIGATED PHAGE DISPLAY LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 17/436494
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436494 | Methods of making and utilizing amber-obligated phage display libraries | Mar 3, 2020 | Issued |
Array
(
[id] => 17975878
[patent_doc_number] => 11492728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Variant nucleic acid libraries for antibody optimization
[patent_app_type] => utility
[patent_app_number] => 16/802439
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 26711
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/802439 | Variant nucleic acid libraries for antibody optimization | Feb 25, 2020 | Issued |
Array
(
[id] => 17975877
[patent_doc_number] => 11492727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Variant nucleic acid libraries for GLP1 receptor
[patent_app_type] => utility
[patent_app_number] => 16/802423
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 116
[patent_no_of_words] => 41191
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/802423 | Variant nucleic acid libraries for GLP1 receptor | Feb 25, 2020 | Issued |
Array
(
[id] => 16376627
[patent_doc_number] => 20200325469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => FOCUSED LIBRARIES OF GENETIC PACKAGES
[patent_app_type] => utility
[patent_app_number] => 16/789468
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789468 | FOCUSED LIBRARIES OF GENETIC PACKAGES | Feb 12, 2020 | Abandoned |
Array
(
[id] => 16013517
[patent_doc_number] => 20200181601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS
[patent_app_type] => utility
[patent_app_number] => 16/752140
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752140 | OB-fold used as scaffold for engineering new specific binders | Jan 23, 2020 | Issued |